Reproduction and Fertility is an open-access, peer-reviewed journal
Page URL: https://www.bionews.org.uk/page_90229

Controversial embryonic stem cell paper clarified

27 November 2006
Appeared in BioNews 386

The journal Nature this week published clarification of a controversial research paper which claimed that embryonic stem cell (ES cell) lines could be produced by extracting a single cell from an early embryo without destroying the embryo. Dr Robert Lanza of US biotechnology company Advanced Cell Technologies and his team used an approach similar to PGD to remove a single cell from an early embryo. A number of single cells removed from early embryos were then grown in culture to generate ES cell lines. The results showed that it was possible to create stem cell lines without needing to destroy embryos, however in the experiment the team had used multiple cells from individual embryos to minimise the number of embryos used. All of the embryos used in the research were, in fact, destroyed.

The usual method of creating ES cell lines uses later embryos than those used in Lanza's work, and always results in the embryo being destroyed. The work was criticised by Catholic Bishops in the US, and by supporters of stem cell research in Congress, who said that the fact that embryos were destroyed to demonstrate the principle that single cells could be used to derive cell lines, hurt their cause. The clarification in Nature affirmed the scientific validity of the research but also itemises changes that have been made to the text that were misunderstood or mis-stated at the time. Primarily the clarification addresses the claim that others could use the technique to create cell lines without harming embryos, whereas Lanza and his team had in fact destroyed the embryos on which they worked. If the researchers had taken only a single cell from each embryo, a much larger number of embryos would have been needed to generate the number of cell lines they successfully derived.

Nature's chief biology editor, Dr Ritu Dhand, commented, 'There was nothing either scientifically or technically wrong with the paper'. The paper was also subjected to a second round of peer review to check that everything was in order. In the clarification the authors point out that they have not excluded the possibility that only a subset of the cells from early embryos can form human ES cell lines. Another possible caveat to the research pointed out in the clarification is that the isolated cells from the original embryo were cultured in the same medium as the parent embryo. The authors suggest that, 'diffusible factors from the other blastomeres present in the media may assist recovery and growth'. Despite this the authors assert that, 'these caveats are worth considering for future studies, but do not negate our central finding that blastomeres extracted from an 8-10 cell embryo by mechanical micromanipulation can form human embryonic stem-cell cultures'.

SOURCES & REFERENCES
Company clarifies controversial stem cell study
Yahoo Daily News |  22 November 2006
Human embryonic stem cell lines derived from single blastomeres
Nature |  23 November 2006
Journal Clarifies Stem-Cell Report
The New York Times |  22 November 2006
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
14 January 2008 - by Dr Charlotte Maden 
A team of researchers in the US has created human embryonic stem cell (hESC) lines without destroying the embryos in the process. They hope these findings will change the legislation limiting federal funding for hESC research in the US. The scientists at Advanced Cell Technology (ACT), in...
17 September 2006 - by Heidi Nicholl 
American biotech company WiCell, based in Wisconsin, has agreed to help distribute any stem cell lines created using a new, still controversial, technique developed by Advanced Cell Technologies (ACT). The new technique was reported in Nature on 24 August and describes a 'proof of principle' that stem...
11 September 2006 - by Dr Jess Buxton 
The authors of a recent study describing a new way of extracting human embryonic stem (ES) cells have been accused of 'hyping' their results. The research, published by US firm Advanced Cell Technology (ACT) in the journal Nature on 24 August, reported the isolation of new...
HAVE YOUR SAY
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.